Skip to main content
. 2023 Oct 6;72(40):1083–1088. doi: 10.15585/mmwr.mm7240a2

TABLE 1. Characteristics of adults aged ≥60 years hospitalized with respiratory syncytial virus, COVID-19, or influenza — Investigating Respiratory Viruses in the Acutely Ill Network, 25 hospitals,* 20 U.S. states, February 1, 2022–May 31, 2023.

Characteristic No. (%)
Total 
N = 5,784 RSV 
n = 304 COVID-19 
n = 4,734 Influenza 
n = 746
Age, yrs, median (IQR)
74 (67–81)
72 (66–80)
74 (67–82)
71 (65–79)
Age group, yrs
60–69
2,038 (35.2)
116 (38.2)
1,601 (33.8)
321 (43.0)
70–79
1,978 (34.2)
110 (36.2)
1,623 (34.3)
245 (32.8)
≥80
1,768 (30.6)
78 (25.7)
1,510 (31.9)
180 (24.1)
Race and ethnicity
Black or African American, non-Hispanic
1,038 (17.9)
55 (18.1)
795 (16.8)
188 (25.2)
White, non-Hispanic
3,659 (63.3)
178 (58.6)
3,095 (65.4)
386 (51.7)
Hispanic or Latino, any race
702 (12.1)
44 (14.5)
543 (11.5)
115 (15.4)
Other race, non-Hispanic
293 (5.1)
22 (7.2)
224 (4.7)
47 (6.3)
Other§
92 (1.6)
5 (1.6)
77 (1.6)
10 (1.3)
Sex
Female
2,898 (50.1)
173 (56.9)
2,326 (49.1)
399 (53.5)
Male
2,886 (49.9)
131 (43.1)
2,408 (50.9)
347 (46.5)
HHS region*
1
1,117 (19.3)
41 (13.5)
971 (20.5)
105 (14.1)
2
337 (5.8)
27 (8.9)
239 (5.0)
71 (9.5)
3
221 (3.8)
8 (2.6)
199 (4.2)
14 (1.9)
4
998 (17.3)
59 (19.4)
812 (17.2)
127 (17.0)
5
881 (15.2)
37 (12.2)
712 (15.0)
132 (17.7)
6
676 (11.7)
25 (8.2)
550 (11.6)
101 (13.5)
7
328 (5.7)
29 (9.5)
246 (5.2)
53 (7.1)
8
731 (12.6)
51 (16.8)
574 (12.1)
106 (14.2)
9
295 (5.1)
19 (6.3)
257 (5.4)
19 (2.6)
10
200 (3.5)
8 (2.6)
174 (3.7)
18 (2.4)
No. of organ systems with a chronic medical condition, median (IQR)
2 (2–3)
2 (2–3)
2 (2–4)
2 (2–3)
COVID-19 vaccination status**
Unvaccinated
997 (17.2)
29 (9.5)
837 (17.7)
131 (17.6)
Vaccinated††
4,713 (81.5)
274 (90.1)
3,834 (81.0)
605 (81.1)
Influenza vaccination status§§
Unvaccinated
2,548 (44.1)
131 (43.1)
2,026 (42.8)
391 (52.4)
Vaccinated¶¶ 2,795 (48.3) 147 (48.4) 2,343 (49.5) 305 (40.9)

Abbreviations: HHS = U.S. Department of Health and Human Services; RSV = respiratory syncytial virus.

* Hospitals by HHS region include Region 1: Baystate Medical Center (Springfield, Massachusetts), Beth Israel Deaconess Medical Center (Boston, Massachusetts), and Yale University (New Haven, Connecticut); Region 2: Montefiore Medical Center (New York, New York); Region 3: Johns Hopkins Hospital (Baltimore, Maryland); Region 4: Emory University Medical Center (Atlanta, Georgia), University of Miami Medical Center (Miami, Florida), Vanderbilt University Medical Center (Nashville, Tennessee), and Wake Forest University Baptist Medical Center (Winston-Salem, North Carolina); Region 5: Cleveland Clinic (Cleveland, Ohio), Hennepin County Medical Center (Minneapolis, Minnesota), Henry Ford Health (Detroit, Michigan); The Ohio State University Wexner Medical Center (Columbus, Ohio), and University of Michigan Hospital (Ann Arbor, Michigan); Region 6: Baylor Scott & White Medical Center (Temple, Texas) and Baylor University Medical Center (Dallas, Texas); Region 7: Barnes-Jewish Hospital (St. Louis, Missouri) and University of Iowa Hospitals (Iowa City, Iowa); Region 8: Intermountain Medical Center (Murray, Utah) and UCHealth, University of Colorado Hospital (Aurora, Colorado); Region 9: University of Arizona Medical Center (Phoenix, Arizona), Stanford University Medical Center (Stanford, California), and UCLA Medical Center (Los Angeles, California); and Region 10: Oregon Health & Science University Hospital (Portland, Oregon) and University of Washington (Seattle, Washington).

Other race, non-Hispanic includes American Indian or Alaska Native, Asian, and Native Hawaiian or other Pacific Islander, which were combined because of small counts.

§ Other includes patients who self-reported their race and ethnicity as “other” and those for whom race and ethnicity were unknown.

Organ systems with chronic medical conditions include cardiovascular disease, neurologic disease, pulmonary disease, gastrointestinal disease, endocrine disease, kidney disease, hematologic disease, autoimmune disease, and immunocompromising conditions.

** A total of 74 (1.3%) patients were missing COVID-19 vaccination status, including one (0.3%) among RSV patients, 63 (1.3%) among COVID-19 patients, and 10 (1.3) among influenza patients.

†† Includes patients with receipt of ≥1 dose of original (ancestral) monovalent vaccines, specifically BNT1262b2, (Pfizer-BioNTech), mRNA-1273 (Moderna), NVX-CoV2373 (Novavax), Ad26.COV2.S (Janssen [Johnson & Johnson]) or patients with receipt of ≥1 dose bivalent (ancestral and BA.4/5) vaccines, specifically BNT1262b2 bivalent vaccine (Pfizer-BioNTech) and mRNA-1273.222 (Moderna) bivalent vaccine. Patients who received bivalent vaccination might have previously received 1–6 doses of the original (ancestral) monovalent vaccines.

§§ A total of 441 (7.6%) patients were missing influenza vaccination status, including 26 (8.6%) RSV patients, 365 (7.7%) COVID-19 patients, and 50 (6.7%) influenza patients.

¶¶ Patients were classified as vaccinated against influenza if they received season-specific influenza vaccination based on the period in which they were enrolled.